What is PrEP? Coformulated tenofovir and emtricitabine (TDF/FTC) has been proven to be effective as pre-exposure prophylaxis (PrEP) for HIV. When taken as prescribed, PrEP can reduce the risk of sexually transmitted HIV by up to 99%.
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.